Randomised Phase II Study of Epirubicin-Vindesine Versus Mitoxantrone-Vindesine in Metastatic Breast Cancer

Author: Hausmaninger H.   Lehnert M.   Steger G.   Sevelda P.   Tschurtschenthaler G.   Hehenwarter W.   Fridrik M.   Samonigg H.   Schiller L.   Manfreda D.   Haidinger R.   Kienzer R.   Kemmler G.  

Publisher: Elsevier

ISSN: 0959-8049

Source: European Journal of Cancer, Vol.31, Iss.13, 1995-12, pp. : 2169-2173

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content